Tolerability of ketorolac administered via continuous subcutaneous infusion for cancer pain: A preliminary report

Franco De Conno, Ernesto Zecca, Cinzia Martini, Carla Ripamonti, Augusto Caraceni, Luigi Saita

Research output: Contribution to journalArticlepeer-review

Abstract

We evaluated the local and systemic tolerability of ketorolac administered through continuous subcutaneous infusion in ten cancer patients. The patients were monitored daily for the severity and duration of pain, and the development of other symptoms. The duration of injection site varied from 1 to more than 7 days. No patients complained of local discomfort or pain. Mild local bleeding at the site of drug injection was observed in seven cases. No increase in the intensity of symptoms was observed during the infusion of ketorolac.

Original languageEnglish
Pages (from-to)119-121
Number of pages3
JournalJournal of Pain and Symptom Management
Volume9
Issue number2
DOIs
Publication statusPublished - 1994

Keywords

  • cancer pain
  • Ketorolac
  • subcutaneous

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Fingerprint Dive into the research topics of 'Tolerability of ketorolac administered via continuous subcutaneous infusion for cancer pain: A preliminary report'. Together they form a unique fingerprint.

Cite this